Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James G Herman

Showing results (11-20 of 259) with videos related to

Pageof 26
Sort By:
The New England Journal of Medicine|November 25, 2003
Gene silencing in cancer in association with promoter hypermethylationJames G Herman, Stephen B Baylin
Cancer Discovery|November 14, 2012
Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancersJoshi J Alumkal, James G Herman
Epigenomics|September 8, 2015
Epigenome-based personalized medicine in human cancerWenji Yan, James G Herman, Mingzhou Guo
Oncotarget|March 12, 2016
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancerDan Gao, James G Herman, Mingzhou Guo
Methods in Molecular Biology (Clifton, N.J.)|November 7, 2008
Methylation-specific PCRJulien D F Licchesi, James G Herman
Blood Reviews|January 24, 2006
The fundamental role of epigenetics in hematopoietic malignanciesOliver Galm, James G Herman, Stephen B Baylin
Epigenetics|March 5, 2021
DNA-methylation for the detection and distinction of 19 human malignanciesLudmila Danilova, John Wrangle, James G Herman, et al.
Human Pathology|November 28, 2002
Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosusEnrique Lerma, Manel Esteller, James G Herman, et al.
Cancer Investigation|February 10, 2006
Methylated tumor-specific DNA as a plasma biomarker in patients with gliomaKyle D Weaver, Stuart A Grossman, James G Herman
International Journal of Andrology|November 8, 2017
Cryptorchidism and non-seminomatous testis cancerJames G Herman, Nigel V Hawkins, W D Rider
Pageof 26

Showing results (11-20 of 259) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|November 25, 2003
Gene silencing in cancer in association with promoter hypermethylationJames G Herman, Stephen B Baylin
Cancer Discovery|November 14, 2012
Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancersJoshi J Alumkal, James G Herman
Epigenomics|September 8, 2015
Epigenome-based personalized medicine in human cancerWenji Yan, James G Herman, Mingzhou Guo
Oncotarget|March 12, 2016
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancerDan Gao, James G Herman, Mingzhou Guo
Methods in Molecular Biology (Clifton, N.J.)|November 7, 2008
Methylation-specific PCRJulien D F Licchesi, James G Herman
Blood Reviews|January 24, 2006
The fundamental role of epigenetics in hematopoietic malignanciesOliver Galm, James G Herman, Stephen B Baylin
Epigenetics|March 5, 2021
DNA-methylation for the detection and distinction of 19 human malignanciesLudmila Danilova, John Wrangle, James G Herman, et al.
Human Pathology|November 28, 2002
Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosusEnrique Lerma, Manel Esteller, James G Herman, et al.
Cancer Investigation|February 10, 2006
Methylated tumor-specific DNA as a plasma biomarker in patients with gliomaKyle D Weaver, Stuart A Grossman, James G Herman
International Journal of Andrology|November 8, 2017
Cryptorchidism and non-seminomatous testis cancerJames G Herman, Nigel V Hawkins, W D Rider
Pageof 26